KTRA - Kintara Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

15.72M

Cash

6.547M

Avg Qtr Burn

-1.811M

Short % of Float

1.78%

Insider Ownership

0.13%

Institutional Own.

0.97%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
REM-001 Details Metastatic breast cancer, Cancer	Phase 2/3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
IFX-Hu2.0 Details Cancer, Metastatic merkel cell carcinoma, Cutaneous squamous cell carcinoma	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VAL-083 Details Glioblastoma, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.